Compilation: Tumor Information Source: Tumor Information
November 10, 2017-November 12, 2017 "2017 third lung cancer precision diagnosis and treatment Qianjiang Forum and the third Zhejiang Tumor Precision Diagnosis and Treatment Seminar and the 2nd Hangzhou Hunhu Breast Cancer Mid -Youth Forum "was successfully held on the banks of the Qiantang River in Hangzhou. The conference brought together a number of leaders in the field of lung cancer in China, and accurate diagnosis and treatment experts from Zhejiang Province and the country from Zhejiang Province and the whole country had no seats in the venue. The conference was sponsored by Zhejiang Cancer Hospital, Zhejiang Anti -Cancer Association, and Zhejiang Provincial Transformation Medical Association. Mao Weimin and Professor Wu Yilong were invited to be chairman of the conference. Oncology information is specially invited by Professor Fan Yun, the highlight of our forum.
Tumor Information: Every year, the Qianjiang Forum of the Qianjiang Forum is crowded, and the clinicians have a lot of new information and new information information, which also gives us a good learning opportunity. This year is the third forum. Compared with previous years, what are the changes in the agenda and what are the new highlights and characteristics?
Professor Fan Yun: In the past few years, especially in the past two years, the media is very developed, especially from the media. The very good result of this is that we can get new information anytime, anywhere, and we can see the latest progress of our tumor at any time in our work and rest time. In addition, there are many meetings, especially in the second half of the year, there are many meetings across the country. How to hold a meeting is the focus of our thinking. The Qianjiang Forum of Qianjiang Forum has been carried out to the third session. When the agenda is set up, we also consider the current status. There are a lot of meetings and a lot of information. During the meeting, I really learned and heard something, and it helped clinical help. Considering these backgrounds, our meeting focuses on two aspects. First, focus on cutting -edge progress. New things may not be used now, but in the future, we will definitely use it in the future. Second, pay attention to the problems of clinical treatment, how to solve these reality problems. We hope that this platform that will come to build can bring this information from these two aspects. Our agenda settings are also considering these aspects. In the first aspect of
, the cutting -edge treatment of lung cancer. We focus on two aspects, the key to targeted therapy and precise tumor treatment. Second, the popular topic in recent years - immunotherapy . Immunotherapy looks far away, but many of us are actually in use. They buy this medicine from various channels, and they have this demand. We put immunotherapy at the forefront. I hope that through the setting of our agenda, everyone will understand that when using these drugs, what we need to pay attention to, where is the future development direction, and in combination with these studies, which aspects can we from? Carry out research. The main topic of the morning meeting is the cutting -edge progress of lung cancer. Generally speaking, the effect is very good. The experts of the lectures we invited are from experts in the country's most famous lung cancer. They not only bring the latest information about the tumor, but also share some of their clinical experience and answer questions on the spot. Very meaningful. In the second aspect of
, we want to solve some practical problems encountered by clinicians, such as optimization of chemotherapy. At present, internationally, the second -line standard treatment of patients with squamous carcinoma is immunotherapy, but we have no medicine. In China, how do we optimize the treatment, we have set up a special session to solve some problems encountered in chemotherapy. Some experts at the scene also mentioned many interesting topics in questions, which are quite helpful. In addition, we talk a lot about targeted therapy. The key to targeted treatment is to detect. I need to have a good detection method, good detection specimen, and good detection platform to have good test results. Without testing, the treatment is equivalent to the air tower. Therefore, we also set up the detection link. How to make our tests more accurate is the second clinical practice we think of.Third, in addition to precise treatment, there are many issues in the treatment of lung cancer that everyone is more concerned about, such as the differential diagnosis of small lung nodules. At present, more screenings are done, and many patients will find small nodules in the lungs. How to deal with them. In the oncology department, we focus on treatment rather than diagnosis. Many diagnoses are done by the respiratory department. Therefore, we have also set up a special session on the diagnosis of small pulmonary nodules, focusing on the diagnosis of small nodules and how to identify benign and malignant nodules. question. Finally, precision therapy is very popular now, but there are still many shortcomings in precision therapy. How can we avoid the traps that precision therapy brings us? What I deeply understand is that some of our patients have undergone very expensive testing, and the results obtained are that there is no driver gene that can be treated. In the end, the patient underwent multiple lines of chemotherapy, and his PS score was very poor, but he still had a very strong desire to survive. At this time, we suggested that the patient be tested again. After doing a new NGS test, we found that he was an ALK-positive patient. Therefore, there are still many pitfalls in so-called precision medicine. In the stages of testing, research, and clinical practice, how can we avoid the pitfalls of precision therapy? What is the future development direction of precision therapy? In this special session, we invited Professor Zhou Caicun to give a report in this area, explaining the current problems of accurate treatment and the future development direction.
Lung cancer topic and other settings are basically the same as mentioned above. In addition to the setting of this topic, we also considered the treatment of other tumors. Our conference is not only the Qianjiang Forum on Precision Diagnosis and Treatment of Lung Cancer, but also involves the precision treatment of tumors. It also includes the Precision Diagnosis and Treatment of Digestive Tract Malignant Tumors and the Hangzhou Forum. The Xianghu Breast Cancer Young and Middle-aged Forum focuses on precision treatment of the breast and gastrointestinal tract, as well as some treatment progress in precision-related fields. We also set up a special session - MDT teams from various hospitals in Zhejiang Province. These MDT teams will compete with the teams selected after preliminary screening in each region. Judging from the on-site results, it was very good. Each team came up with very interesting cases to evaluate from all aspects what problems may exist in our diagnosis and treatment, what loopholes there are, and how to fill the gaps in our current knowledge and clinical practice. problems, thereby achieving a better treatment effect. Therefore, the experts participating in the competition and the MDT expert team have all improved in the process, which is very helpful to their clinical improvement. Before the MDT competition, we specially invited Professor Zhou Qing from Guangdong Provincial People's Hospital to give a speech on how to make a good medical speech. Judging from the reactions of our experts present, the effect is very good, such as how to prepare PPT, how to give a PPT speech, how to face the audience, clothing preparation and many on-site details. Many doctors have needs in this area. We not only need to do clinical work, clinical research, and translational research, but we also need to express ourselves and communicate with everyone. One of the ways of communication is to give speeches.
Cancer Information: From a clinical perspective, in the past two years, there have been some real changes and actual achievements in the treatment of lung cancer in Zhejiang Province. Please give us some details.
Professor Fan Yun: First of all, we will introduce the clinical practice methods. For example, in yesterday’s MDT team competition, there were 4 MDT team competitions participating. For example, Jinhua area formed a team, and elite doctors from many hospitals in Jinhua area organized to participate in the competition. , there is a team in Ningbo area, and there is a team in Zhejiang Cancer Hospital. Judging from the situation of the MDT team competition in grassroots hospitals, I think that even in our relatively grassroots hospitals, the overall diagnosis and treatment level is acceptable. After everyone’s efforts over the past few years, our standardized treatment has been going well.
Tumor Information: Thank you Professor Fan Yun, thank you all. I hope that under the leadership of authoritative experts such as Professor Fan Yun, our cancer industry in Zhejiang Province can be at the forefront of our country and the world. Thank you.
Editor in charge: Tumor Information-Tim Copyright Statement Copyright belongs to Tumor Information.Individuals are welcome to forward and share. If any other media or website needs to reprint or quote the copyrighted content of this website, it must obtain authorization and indicate "Reprinted from: Good Doctors - Oncology Doctor APP" in a prominent position.
